APH
Amphenol Corporation
APH has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has a slight edge over APH overall, supported by stronger fundamentals.
APH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Healthy |
APH's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
APH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $79.62 | — |
| Cheap | 26x | $60.41 | -24% |
| Fair | 33x | $76.08 | -4.4% |
| Current | 35x | $79.62 | — |
| Expensive | 42x | $96.05 | +21% |
Historical ranges are pointers, not guarantees.
APH's PE is in its fair range at 35x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over APH in the historical PE scenario, which offers more potential upside but is not a forecast.
APH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for APH, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
APH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.46 | +50% |
| Q3 2026 | $2.30 | +53% |
| Q2 2026 | $1.99 | +58% |
| Q1 2026 | $1.74 | +69% |
| Q4 2025 | $1.67 | +74% |
| Q3 2025 | $1.50 | +72% |
| Q2 2025 | $1.26 | +50% |
| Q1 2025 | $1.03 | +26% |
| Q4 2024 | $0.96 | +23% |
APH's earnings per share have climbed steadily: $2.30 over the past year, up 53% from the year before, and higher year over year every quarter since late 2020.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over APH in the latest year-over-year earnings comparison.
APH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.2B | +65% |
| Q2 2026 | $8.8B | +55% |
| Q1 2026 | $7.6B | +58% |
| Q4 2025 | $6.4B | +49% |
| Q3 2025 | $6.2B | +53% |
| Q2 2025 | $5.7B | +57% |
| Q1 2025 | $4.8B | +48% |
| Q4 2024 | $4.3B | +30% |
APH has the edge over SNDK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +2.1 points |
| Q2 2026 | 30% | +4.4 points |
| Q1 2026 | 24% | +2.7 points |
| Q4 2025 | 27% | +4.7 points |
| Q3 2025 | 27% | +7.2 points |
| Q2 2025 | 25% | +5.8 points |
| Q1 2025 | 21% | +0.3 points |
| Q4 2024 | 22% | +1.4 points |
APH's operating margin was 30% last quarter, up 2.1 points from the same quarter a year ago, near the top of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over APH on profitability, with a higher operating margin.
APH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +34% |
| Q2 2026 | $1.2B | +7.3% |
| Q1 2026 | $829.9M | +44% |
| Q4 2025 | $1.5B | +127% |
| Q3 2025 | $1.2B | +156% |
| Q2 2025 | $1.1B | +114% |
| Q1 2025 | $576.3M | +14% |
| Q4 2024 | $647.3M | -12% |
APH has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
APH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +4.5M shares |
| 1 year | +0.7% | +17.3M shares |
| 3 years | +3.8% | +94.9M shares |
| 5 years | +3.2% | +79.7M shares |
| Available history | +4.9% | +120M shares |
APH has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $244.6M |
| Q2 2026 | $208M |
| Q1 2026 | $178M |
| Q4 2025 | $171.3M |
| Q3 2025 | $152.9M |
| Q2 2025 | $160.1M |
| Q1 2025 | $180.9M |
| Q4 2024 | $168.9M |
APH spent $802M buying back its own shares over the past year, up 21% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
APH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.0x | Very low |
APH's net debt is about 1.3 years of its operating earnings (EBITDA), up from less than a year a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over APH on leverage, with a lower net debt burden relative to earnings.
APH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 36.3 | Neutral |
APH's weekly RSI is 52 (neutral) and its Stochastic is 36 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
APH PE vs Technology Sector
| Metric | APH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 24% above |
| PE % | 59 | 35 | 24 pts above |
APH is trading at 35x earnings, a 24% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over APH on valuation relative to its sector.
APH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.7 | 1.3% below |
| 20 week MA | $80.5 | 1% below |
| 50 week MA | $74.5 | 6.9% above |
| 100 week MA | $60.8 | 31% above |
| 200 week MA | $43.4 | 83% above |
APH has stronger trend alignment. APH is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
APH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.5 | $16.2 | +20% |
| 2021 | $16.2 | $21.3 | +32% |
| 2022 | $21.3 | $19.0 | -11% |
| 2023 | $19.0 | $24.8 | +31% |
| 2024 | $24.8 | $35.4 | +43% |
| 2025 | $35.4 | $68.7 | +94% |
| 2026 YTD | $68.7 | $79.6 | +16% |
APH has finished higher in five of the last six years. It's up 16% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over APH on returns for 2026, with the stronger performance.